Effect of a Psychoeducational-Developmental Support Program on Adolescents' Relative Deprivation, Distress Levels, Peer Relations and Basic Psychological Needs (PDSP)

December 5, 2025 updated by: Aziz Küçükkelepçe

Examination of the Effect of a Psychoeducational-Developmental Support Program on Adolescents' Relative Deprivation, Distress Levels, Peer Relationships, and Basic Psychological Needs

This study aims to examine the effectiveness of a Psychoeducational-Developmental Support Program on adolescents' distress-eustress levels, relative deprivation, peer relationships, and basic psychological needs. The program will be implemented with high school students using a pre-test/post-test control group design. The 11-week intervention includes structured psychoeducational and developmental activities. Assessments of distress-eustress, relative deprivation, peer relations, and basic psychological needs will be conducted before and after the intervention. A follow-up test will be administered one month later. The program is expected to produce significant improvements in adolescents' psychological and social functioning.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Not yet recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

This study investigates the effectiveness of an 11-week Psychoeducational-Developmental Support Program in reducing adolescents' distress-eustress levels and relative deprivation, while supporting peer relationship quality and the satisfaction of basic psychological needs. The program was developed based on a needs analysis conducted with teachers and incorporates structured psychoeducational content and developmental support activities tailored to adolescents.

The study employs a pre-test/post-test control group experimental design with high school students from three districts in Istanbul. The intervention group will receive weekly psychoeducational-developmental sessions, whereas the control group will receive no intervention. Measurements will include the Distress-Eustress Scale for Adolescents (Turkish Form), the Relative Deprivation Scale-Adolescent Form, the Peer Relations Scale, and the Basic Psychological Needs at School Scale. A retention assessment will be conducted one month after the intervention to evaluate the sustainability of the program's effects.

Data will be analyzed using the Mann-Whitney U test, the Wilcoxon Signed-Rank test, and effect size calculations (p < .05). The program is expected to lead to meaningful and lasting improvements in adolescents' emotional and psychosocial well-being.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
60

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria: *High school students enrolled in selected schools in Istanbul.

  • Aged 14-18 years.
  • Able to participate in weekly psychoeducational-developmental sessions.
  • Provide informed assent (and parental consent where required).

Exclusion Criteria: * Students with severe cognitive or developmental impairments that prevent participation.

  • Students currently receiving psychological treatment specifically targeting distress or related constructs.
  • Failure to obtain parental consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Intervention Group
Participants will receive the Psychoeducational-Developmental Support Program delivered once per week for 11 weeks.
Behavioral: Psychoeducational-Developmental Support Program
The Psychoeducational-Developmental Support Program is an 11-week structured behavioral intervention developed through needs analysis with teachers. The program includes weekly sessions containing psychoeducational and developmental support activities designed to reduce distress-eustress imbalance, decrease relative deprivation, and strengthen peer relationships and basic psychological needs.
No Intervention: Control Group
Participants will receive no intervention during the study period. Pre-test and post-test assessments will be conducted.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Distress-Eustress Levels
Time Frame: Baseline (pre-test) and post-intervention (11 weeks).
Change in adolescents' distress-eustress levels from pre-test to post-test as measured by the Distress-Eustress Scale for Adolescents (Turkish Form). Higher distress scores indicate greater emotional strain; higher eustress scores indicate positive stress response.
Baseline (pre-test) and post-intervention (11 weeks).

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Relative Deprivation
Time Frame: Baseline and post-intervention (11 weeks).
Change in adolescents' perceived relative deprivation measured by the Relative Deprivation Scale-Adolescent Form from pre-test to post-test. Higher scores indicate greater perceived deprivation.
Baseline and post-intervention (11 weeks).
Peer Relationships
Time Frame: Baseline and post-intervention (11 weeks).
Change in adolescents' peer relationship quality measured by the Peer Relations Scale from pre-test to post-test. Higher scores indicate better peer relationship functioning.
Baseline and post-intervention (11 weeks).
Basic Psychological Needs at School
Time Frame: Baseline and post-intervention (11 weeks).
Change in adolescents' satisfaction of basic psychological needs measured by the Basic Psychological Needs at School Scale from pre-test to post-test. Higher scores indicate greater need satisfaction.
Baseline and post-intervention (11 weeks).

Other Outcome Measures

Other Outcome Measures

For clinical trials, a planned measurement described in the protocol that is used to determine the effect of an intervention/treatment on participants. For observational studies, a measurement or observation that is used to describe patterns of diseases or traits, or associations with exposures, risk factors, or treatment. Types of outcome measures include primary outcome measure and secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Retention of Program Effects
Time Frame: 1 month post-intervention
One-month follow-up assessment administered to the experimental group to evaluate the persistence of intervention effects on distress-eustress, relative deprivation, peer relationships, and basic psychological needs.
1 month post-intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Aziz Küçükkelepçe

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Study Director: Haktan Demircioğlu, Assoc. Prof. Dr., Hacettepe University, Faculty of Health Sciences

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
February 1, 2026

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
June 1, 2026

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
September 1, 2026

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
December 5, 2025

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
December 5, 2025

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
December 18, 2025

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
December 18, 2025

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
December 5, 2025

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
December 1, 2025

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • HÜ-EK-2024/13 (Other Identifier: Hacettepe University)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

No individual participant data will be shared due to confidentiality requirements and restrictions specified by the ethics committee for underage participants.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Adolescent Psychological Well-being

Clinical Trials on Psychoeducational-Developmental Support Program

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings